Melek Yorgun Altunbaş

Also affiliated with Center for Translational Molecular Medicine, Jeffrey Modell Foundation, Immune Deficiency Foundation, Marmara University

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study”.

Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

The Lancet(2024)10.1016/s0140-6736(23)02358-9

N/A

0.995DataRank · unranked

28 citations

Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher +35 more

Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients

Clinical Immunology(2023)10.1016/j.clim.2023.109757

N/A

0DataRank · unranked

12 citations

Alexandra Y. Kreins, Mehmet Cihangir Çatak, Royala Babayeva, Baran Erman, Heather Kenney +34 more